NPR – Share prices for the British drugmaker Indivior plunged today on the London Stock Exchange. The drop came on news that the U.S. Justice Department indicted the company on fraud and conspiracy charges.
Business Law
Many sue OxyContin maker, but not its own city: Stamford
Opioids: Boston trial opens what could be year of reckoning for executives
Purdue Pharma to research non-opioid treatments
Daily Heralds – Purdue Pharma, the controversial maker of OxyContin, and eyecare-pharmaceutical firm Ocular Therapeutix has announced a research partnership aiming to develop non-opioid pain treatments.
Purdue Pharma grapples with growing protests
Congressional Committee Investigates Purdue Pharma
Beleaguered Purdue Pharma Makes Leadership Changes
Studying for the Bar? Put Down the Phone — Or Not
ABA Journal– The days of attending bar review classes in person are waning, say law school deans, and recent graduates preparing for the bar now do a great deal of studying on smartphones with offerings like streamed lectures, flashcard apps and even YouTube songs devoted to thinking through statutes and case law.
Purdue Pharma Faces Private-Sector Litigation
With Less Than 80 Days to Regulatory Deadline, Neo4j Urges Organizations to Turn GDPR Compliance Into Strategic Advantage
PR Newswire– In lead-up to GDPR’s looming May 25, 2018 deadline, Neo4j, the market leader in connected data, is urging any company that is investing in GDPR compliance to use those investments for a long-term, strategic advantage. As part of that effort, Neo4j is offering an interactive, personalized demonstration and solution assessment, which shows organizations how to use connected data to meet GDPR compliance, and also how to turn those compliance investments into a strategic advantage.